Atlantic International (ATLN)
NASDAQ:ATLN
Want to see ATLN full AI Analyst Report?
Top Page
Atlantic International
(NASDAQ:ATLN)
Select Model
Select Model
Rating:42Neutral
Price Target:
$1.50
▼(-66.29% Downside)
Action:Reiterated
Date:05/07/26
The score is primarily weighed down by weak financial performance (continued losses, negative equity, and negative cash flow) and bearish technicals (below key moving averages with negative MACD). Valuation provides limited support due to negative earnings, while corporate events are mixed—financing helps near-term liquidity but litigation and governance issues increase risk.
Positive Factors
Institutional financing and runway
The $5.6M institutional preferred financing provides a multi-month liquidity runway and formal institutional support, reducing immediate refinancing pressure. Senior preferred status and investor participation rights improve access to follow‑on capital and stabilize near‑term operations.
Negative Factors
Negative shareholders' equity
Persistent negative equity is a structural solvency concern that limits borrowing capacity and raises creditor control risk. It compresses strategic optionality, can trigger covenant breaches, and weakens shareholder position versus preferred or debt claims over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Institutional financing and runway
The $5.6M institutional preferred financing provides a multi-month liquidity runway and formal institutional support, reducing immediate refinancing pressure. Senior preferred status and investor participation rights improve access to follow‑on capital and stabilize near‑term operations.
Read all positive factors
Atlantic International (ATLN) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$112.69M
Dividend YieldN/A
Average Volume (3M)364.23K
Price to Earnings (P/E)―
Beta (1Y)-0.86
Revenue Growth27.45%
EPS Growth82.80%
CountryUS
Employees300
SectorIndustrials
Sector Strength72
IndustryMedical - Diagnostics & Research
Share Statistics
EPS (TTM)-1.08
Shares Outstanding79,358,270
10 Day Avg. Volume70,257
30 Day Avg. Volume364,234
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-2.27
Price to Sales (P/S)0.17
P/FCF Ratio-16.34
Enterprise Value/Market Cap1.34
Enterprise Value/Revenue0.35
Enterprise Value/Gross Profit3.28
Enterprise Value/Ebitda-3.46
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.61
Revenue Forecast (FY)$481.08M
Atlantic International Business Overview & Revenue Model
Company Description
As of June 18, 2024, Atlantic International Corp. was acquired by Lyneer Investments, LLC, in a reverse merger transaction. Atlantic International Corp. operates as a life sciences instrumentation and research services company. It focuses on devel...
How the Company Makes Money
null...
Atlantic International Financial Statement Overview
Summary
Income Statement
24
Negative
Balance Sheet
12
Very Negative
Cash Flow
18
Very Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 435.88M | 442.61M | 401.37M | 441.54M | 425.03M |
| Gross Profit | 45.99M | 47.18M | 46.88M | 54.21M | 54.41M |
| EBITDA | -43.64M | -113.10M | 1.44M | 11.94M | 12.18M |
| Net Income | -59.43M | -135.48M | -15.25M | -3.22M | -40.80M |
Balance Sheet | |||||
| Total Assets | 113.23M | 122.75M | 126.67M | 8.41M | 10.74M |
| Cash, Cash Equivalents and Short-Term Investments | 81.13K | 678.68K | 1.35M | 6.22M | 9.95M |
| Total Debt | 38.36M | 82.72M | 142.62M | 2.93M | 1.38M |
| Total Liabilities | 145.32M | 134.77M | 166.02M | 4.05M | 2.56M |
| Stockholders Equity | -32.09M | -12.02M | -39.35M | 4.37M | 8.18M |
Cash Flow | |||||
| Free Cash Flow | -4.46M | -6.06M | -9.16M | -3.70M | -2.00M |
| Operating Cash Flow | -4.40M | -5.99M | -9.08M | -3.66M | -1.99M |
| Investing Cash Flow | -66.77K | -73.46K | -73.71K | 1.83M | -5.99M |
| Financing Cash Flow | 3.87M | 5.38M | 8.79M | 0.00 | 12.00M |
Atlantic International Technical Analysis
Negative
4.45
Price Trends
3.22
Negative
2.71
Negative
2.81
Negative
Market Momentum
-0.34
Positive
32.59
Neutral
10.95
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ATLN, the sentiment is Negative. The current price of 4.45 is above the 20-day moving average (MA) of 3.06, above the 50-day MA of 3.22, and above the 200-day MA of 2.81, indicating a bearish trend. The MACD of -0.34 indicates Positive momentum. The RSI at 32.59 is Neutral, neither overbought nor oversold. The STOCH value of 10.95 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ATLN.
Atlantic International Risk Analysis
Atlantic International disclosed 48 risk factors in its most recent earnings report. Atlantic International reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Atlantic International Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | $262.69M | -2.25 | -36.02% | ― | 201.72% | -11.02% | |
54 Neutral | $631.28M | -6.09 | -55.89% | ― | -52.94% | 59.88% | |
51 Neutral | $87.94M | -4.51 | -113.53% | ― | 20.55% | -4.63% | |
42 Neutral | $112.69M | -0.67 | 274.33% | ― | 27.45% | 82.80% | |
42 Neutral | $89.07M | -2.34 | -164.68% | ― | 69.52% | 58.15% | |
41 Neutral | $45.87M | -2.38 | 516.59% | ― | 17.42% | 42.75% |
* Industrials Sector Average
ATLN
Atlantic International
1.42
-1.23
-46.42%
ACRS
Aclaris Therapeutics
4.52
3.22
247.69%
MDXH
MDxHealth
0.89
-1.18
-56.86%
STIM
Neuronetics
1.28
-3.01
-70.16%
XGN
Exagen
3.64
-2.69
-42.50%
PRE
Prenetics Group
15.61
8.68
125.25%
Atlantic International Corporate Events
Business Operations and StrategyExecutive/Board ChangesLegal Proceedings
Atlantic International Challenges Creditor Default Claims in Court
Negative
Apr 3, 2026
On March 30, 2026, SPP Credit Advisors issued default notices to Atlantic International and its Lyneer subsidiaries under both an April 29, 2025 term loan agreement and a June 18, 2024 bridge loan, alleging breaches of financial and non-financial ...
Business Operations and StrategyPrivate Placements and Financing
Atlantic International Completes Institutional Preferred Stock Financing
Positive
Mar 26, 2026
On March 20, 2026, Atlantic International Corp. completed a $5.6 million institutional financing through the issuance of 5,600 shares of newly created Series B 5% Convertible Preferred Stock and accompanying warrants to buy an additional 5,600 pre...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.